Prevalence of Depression and Anxiety Among Breast Cancer Patients

Kazakh Medical University of Continuing Education

Status: Completed

Conditions: Breast Cancer; Depression; Anxiety

Study type: Observational

Funder types: Other

Identifiers

NCT05011409

06-2020

Details and patient eligibility

About

Depression and anxiety in patients with breast cancer is serious comorbidity that affects the quality of life for patients, and their survival rates as they have poorer health outcomes. Furthermore, patients' high psychological burden is linked to higher healthcare costs. The investigation of the depression and anxiety symptoms prevalence among newly diagnosed breast cancer patients will help to navigate the health policy adjustment and psycho-social support system requirements. This study aims to investigate the prevalence of depression and anxiety symptoms among newly diagnosed breast cancer patients in Almaty, Kazakhstan, and associated risk factors.

Enrollment: 162 patients

Sex: Female

Ages: 18 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Female adults with confirmed diagnosis of breast cancer within the 6 months study enrollment
• TNM stage I-IV
• Russian or Kazakh language proficiency
• Ability to provide informed consent

Exclusion criteria

• Current psychotic disorder, manic episode, serious neurological disorder, intellectual disability, or developmental disorder
• Current active suicidal ideation
• Referral to palliative care

Trial design

162 participants in 1 patient group

Newly diagnosed breast cancer patients

Description:

Newly diagnosed breast cancer patients referred to Kazakh Institute of Oncology and Radiology or Almaty Oncology Center will be assessed on the prevalence of depression and anxiety symptoms.